Search research articles
Contact Us
Filters
Showing results (101-110 of 102) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 102 results.
Lancet (London, England)
|
January 28, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
Srdan Verstovsek, Aaron T Gerds, Alessandro M Vannucchi, et al.
The Lancet. Haematology
|
July 30, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Aaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 102) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 102 results.
Lancet (London, England)
|
January 28, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
Srdan Verstovsek, Aaron T Gerds, Alessandro M Vannucchi, et al.
The Lancet. Haematology
|
July 30, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Aaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, et al.
Page
of 11